These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 23214288)

  • 21. [BENEFITS AND RISKS AT IMPLEMENTATION OF PROPHILACTIC VACCINES FOR CERVICAL CANCER].
    Zlatkov V; Kostova P
    Akush Ginekol (Sofiia); 2016; 55(3):28-33. PubMed ID: 27514142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
    Hantz S; Alain S; Denis F
    Gynecol Obstet Fertil; 2006; 34(7-8):647-55. PubMed ID: 16807045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
    Arbyn M; Dillner J
    J Clin Virol; 2007 Mar; 38(3):189-97. PubMed ID: 17258503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer.
    Wheeler CM
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):519-36; vii. PubMed ID: 19061814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
    Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advantages and disadvantages of current prophylactic vaccines against HPV.
    Madrid-Marina V; Torres-Poveda K; López-Toledo G; García-Carrancá A
    Arch Med Res; 2009 Aug; 40(6):471-7. PubMed ID: 19853187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of carcinoma of cervix with human papillomavirus vaccine.
    Gavarasana S; Kalasapudi RS; Rao TD; Thirumala S
    Indian J Cancer; 2000; 37(2-3):57-66. PubMed ID: 11876611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Human papillomavirus: a vaccine against cervical carcinoma uterine].
    Franceschi S
    Epidemiol Prev; 2002; 26(3):140-4. PubMed ID: 12197051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The natural history of cervical HPV infection: unresolved issues.
    Woodman CB; Collins SI; Young LS
    Nat Rev Cancer; 2007 Jan; 7(1):11-22. PubMed ID: 17186016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The HPV vaccination strategy: could male vaccination have a significant impact?
    Brown V; White KA
    Comput Math Methods Med; 2010 Sep; 11(3):223-37. PubMed ID: 20582762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Getting to know human papillomavirus (HPV) and the HPV vaccines.
    Smith GD; Travis L
    J Am Osteopath Assoc; 2011 Mar; 111(3 Suppl 2):S29-34. PubMed ID: 21415377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPV vaccination in Southern Africa: A jab of hope in the fight against cervical cancer.
    Michelow P; Firnhaber C
    Cancer Cytopathol; 2016 Oct; 124(10):695-698. PubMed ID: 27182785
    [No Abstract]   [Full Text] [Related]  

  • 33. The epidemiology behind the HPV vaccine discovery.
    Koutsky L
    Ann Epidemiol; 2009 Apr; 19(4):239-44. PubMed ID: 19344861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus and genital cancer.
    Rapose A
    Indian J Dermatol Venereol Leprol; 2009; 75(3):236-43; quiz 243-4. PubMed ID: 19439875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biology of the papillomavirus infections: V. Vaccine developments].
    Seilles E; Riethmuller D; Mougin C
    Ann Biol Clin (Paris); 1999; 57(5):517-24. PubMed ID: 10518053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias.
    Paavonen J
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S3-9. PubMed ID: 18162244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The epidemiology of human papillomavirus infections.
    Baseman JG; Koutsky LA
    J Clin Virol; 2005 Mar; 32 Suppl 1():S16-24. PubMed ID: 15753008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccines against human papillomavirus and cervical cancer: promises and challenges.
    Mahdavi A; Monk BJ
    Oncologist; 2005 Aug; 10(7):528-38. PubMed ID: 16079320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.
    Monsonego J; Cortes J; Greppe C; Hampl M; Joura E; Singer A
    Vaccine; 2010 Nov; 28(51):8065-72. PubMed ID: 20971114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.